FormBlends has no affiliation, endorsement, or sponsorship relationship with Eli Lilly, the United States Pharmacopeial Convention, the National Association of Boards of Pharmacy, or any pharmacy or institution referenced in this article
The weight loss produced by these compounds, even in the most favorable studies, amounts to approximately 2-4 pounds over 8-12 weeks
Results are mixed across studies and individuals
doi: 10.1001/jama.2023.19897
2028 Translation and linguistic validation of the GENDER-Q into French for use in Canada Trisia Breitkopf 1 , Sylvie Cornacchi 1 , Ines Ndzana Siani 1 , Julia Sapin-Leduc 2 , Flavie Guibert-Pich 2 , Hanya Obsieh 1 , Charlene Rae 1 , Yi Wang 1 , Alexis Laungani 2 , Pierre Brassard 2 , Manraj Kaur 3 , Andrea Pusic 3 , Anne Klassen 1 1 Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada, 2 GrS Montral, Montral, Quebec, Canada, 3 Patient-Reported Outcomes and Values, & Experience Center (PROVE), Brigham and Womens Hospital, Harvard Medical School, Boston, USA Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2028 Aims The GENDER-Q is a new patient-reported outcome measure (PROM) that measures outcomes in gender-affirming care
LEWES, Del., June 23, 2026 (Newswire.com) - Title Reference Notice: Promotional language used in the title above - including "GLP-1 Review 2026" and "What Buyers Need to Know Before Starting" - reflects consumer education framing consistent with how the Omzo brand positions its telehealth weight-loss program at omzo.com
